Drugs / MELSMON
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02749695 | Oct 2013 → Aug 2014 | — | Inna I. Kovalenko | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01931748 Comparator | Apr 2013 → Apr 2014 | — | Unimed Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MELSMON | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01931748 ↗ |
| Route | Subcutaneous | “subcutaneously” NCT02749695 ↗ |